EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Apigenin-7-O-glucoside alleviates DSS-induced colitis by improving intestinal barrier function and modulating gut microbiota

Yeye Hu, Xueting Guan, Ziliang He, Yuan Xie, Zhiqiang Niu, Wei Zhang, Aoran Wang, Ji Zhang, Chuanling Si, Fu Li, Weicheng Hu

Journal of Functional Foods · 2023-05 · 104 · 105499

DOI: 10.1016/j.jff.2023.105499 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Functional Foods, 2023-05. Verfasst von Yeye Hu und 10 weiteren Autor:innen. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Jiangsu Province, Key Technologies Research and Development Program.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Apigenin-7-O-glucoside (AG), a flavonoid glycoside, has been shown in vitro anti-inflammatory activities. To date, the mechanism of AG against colitis has not been reported. In this study, we investigated the role of AG in relieving colitis and explored its potential mechanisms in dextran sulfate sodium (DSS)-induced colitis mice. The results indicated oral administration of AG increased colon length and improved colonic histopathology. Besides, it dramatically restored the colonic expression of pro-inflammatory and anti-inflammatory mediators, as well as enhanced the expression of intestinal barrier markers such as ZO-1, occludin, claudin-1, and claudin-3. The mitogen-activated protein kinases (MAPKs) including ERK, JNK, and p38 were significantly inhibited. Moreover, 16S rDNA sequencing revealed that AG improved the abundance of Akkermansia, and reduced that of Bacteroides and Desulfovibrio. Taken together, AG supplementation relieved DSS-induced colitis by protecting the intestinal barrier, inhibiting the MAPK pathway, and modulating gut microbiota, which indicated that AG may be a good candidate therapeutic compound for sustaining gut health to lower the risk of colitis.

Förderung

  • Natural Science Foundation of Jiangsu Province
  • Key Technologies Research and Development Program

Zitieren

APA

Hu, Y., Guan, X., He, Z., Xie, Y., Niu, Z., Zhang, W., Wang, A., Zhang, J., Si, C., Li, F., & Hu, W. (2023). Apigenin-7-O-glucoside alleviates DSS-induced colitis by improving intestinal barrier function and modulating gut microbiota. Journal of Functional Foods, 104, 105499. https://doi.org/10.1016/j.jff.2023.105499

Vancouver

Hu Y, Guan X, He Z, Xie Y, Niu Z, Zhang W, et al. Apigenin-7-O-glucoside alleviates DSS-induced colitis by improving intestinal barrier function and modulating gut microbiota. Journal of Functional Foods. 2023;104:105499. doi:10.1016/j.jff.2023.105499

BibTeX
@article{Hu2023,
  author = {Hu, Yeye and Guan, Xueting and He, Ziliang and Xie, Yuan and Niu, Zhiqiang and Zhang, Wei and Wang, Aoran and Zhang, Ji and Si, Chuanling and Li, Fu and Hu, Weicheng},
  title = {Apigenin-7-O-glucoside alleviates DSS-induced colitis by improving intestinal barrier function and modulating gut microbiota},
  journal = {Journal of Functional Foods},
  year = {2023},
  volume = {104},
  pages = {105499},
  doi = {10.1016/j.jff.2023.105499}
}
Kostenlos starten →